FORMULATION OF A FAST-DISINTEGRATING TABLET USING MALTODEXTRIN DE 10-15 AND PREGELATINIZATED CASSAVA STARCH AS EXPEDIENTS

  • Ahmad Zaki Department of Pharmacy, Faculty of Pharmacy, Universitas Indonesia, Depok, Indonesia.
  • Effionora Anwa Department of Pharmacy, Faculty of Pharmacy, Universitas Indonesia, Depok, Indonesia.
  • Silvia Surini Department of Pharmacy, Faculty of Pharmacy, Universitas Indonesia, Depok, Indonesia.

Abstract

Objective: Fast-disintegrating tablets are a pharmaceutical preparation that is rapidly being developed because they can dissolve in the oral cavity
without chewing and without additional water support. The type of dissolver is a crucial component in fast-disintegrating tablets. Maltodextrin and
pregelatinized cassava starch (PPS) are excipients that can be used as dissolvers. This study aimed to formulate fast-disintegrating tablets using a
combination of maltodextrin dextrose equivalent (DE) 10-15 and PPS in various concentrations as excipients.
Methods: The cassava starch classified as PPS was obtained. PPS was then mixed with maltodextrin DE 10-15 to create fast-disintegrating tablets
using the wet granulation method.
Results: Tablet evaluation showed that formula F containing 40% maltodextrin DE 10-15 and 10% PPS was the most effective of the proposed fastdisintegrating
tablets.
Conclusions: Formula F has a hardness of 3.39 kp, 0.74% friability, a wetting time of 7.87 seconds, and a dissolve time of 38.55 seconds.

Keywords: Maltodextrin dextrose equivalent 10-15, Fast-disintegrating tablets, Pregelatinized cassava starch.

References

1. Fu Y, Yang S, Jeong SH, Kimura S, Park K. Orally Fast disintegrating
tablets: Developments, technologies, taste-masking and clinical studies.
Purdue university, departments of pharmaceutics and biomedical
engineering, West Lafayette, Indiana, USA. Crit Rev Ther Drug Carrier
Syst 2007;21(6):433-75.
2. Bhowmik D, Chiranjib B, Krishnakanth P, Chandira RM. Fast
dissolving tablet: An overview. J Chem Pharm Res 2009;1(1):163-77.
3. Kennedy JF, Knill CJ, Taylor DW. Maltodextrin. Dalam. In:
Kearsley MW. Dziedzic SZ, editors. Handbook of Starch Hydrolisis
Products and Their Derivatives. London: Blackie Academy dan
Professional; 1995. p. 65-76.
4. Bertolini AC. Starches: Characterization, Properties, and Applications.
New York: CRC Press; 2010. p. 1-2, 166-7.
5. Wade A. dan Weller PJ. Handbook of Pharmaceutical Excipient. 6th ed.
London: The Pharmaceutical Press; 2009. p. 442-4, 731-3.
6. Anwar E, Djajadisastra J, Yanuar A, Bahtiar A. Pemanfaatan
maltodekstrin pati terigu sebagai eksipien dalam formula sediaan tablet
dan niosom. Majalah Ilmu Kefarmasian 2004;1(1):34-6.
7. Gonnissen Y, Remon JP, Vervaet C. Effect of maltodextrin and
superdisintegrant in directly compressible powder mixtures prepared
via co-spray drying. Eur J Pharm Biopharm 2008;68(2):277-82.
8. Rachmawati AL. Pemanfaatan Pregel Pati Singkong Suksinat Sebagai
Eksipien Dalam Pembuatan Tablet Cepat Hancur. Depok: Skripsi
Sarjana FMIPA UI; 2007. p. 45.
9. Departemen Kesehatan Republik Indonesia. Farmakope Indonesia
edisi III. Jakarta: Departemen Kesehatan RI; 1979. p. 6-7.
10. Abu-Izza KA, Li VH, Look JL, Parr GD, Schineller MK. A review on
recent patents on fast dissolving drug delivery system. Int J PharmTech
Res 2009;1(3):790-8.
11. Lachman L, Lieberman HA, Kanig JL. The Theory and Practice of
Industrial Pharmacy. 2nd ed. Philadelphia: Lea dan Febiger; 1986.
p. 139-64, 648-705.
12. Rawas-Qalaji MM, Simons FE, Simons KJ. Fast-disintegrating
sublingual tablet: Effect of epinephrine load on tablet characteristics.
AAPS Pharm Sci Tech 2006:7(2):E41.
13. Takahashi R, Ojima T. Pregelatinization of wheat starch in a drum drier.
In: Bertolini, Andrea C, editors. Starches: Characterization, Properties,
and Applications. New York: CRC Press; 2010. p. 167.
Statistics
214 Views | 339 Downloads
How to Cite
Zaki, A., Anwa, E., & Surini, S. (2017). FORMULATION OF A FAST-DISINTEGRATING TABLET USING MALTODEXTRIN DE 10-15 AND PREGELATINIZATED CASSAVA STARCH AS EXPEDIENTS. International Journal of Applied Pharmaceutics, 9, 71-73. https://doi.org/10.22159/ijap.2017.v9s1.40_46
Section
Original Article(s)